{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:43:13Z","timestamp":1792219393614,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2021 \\u2013 12230\/F1"],"award-info":[{"award-number":["2021 \\u2013 12230\/F1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.diabres.2026.113612","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:55:54Z","timestamp":1791906954000},"page":"113612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence and predictors of the honeymoon phase in type 1 diabetes: A longitudinal study from a tertiary care center of north India"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2267-2523","authenticated-orcid":false,"given":"Saqib","family":"Lone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Badal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1648-7610","authenticated-orcid":false,"given":"Soham","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6317-1269","authenticated-orcid":false,"given":"Parul","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-7929","authenticated-orcid":false,"given":"Preetam","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohini","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8604-4541","authenticated-orcid":false,"given":"Shivangi","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subin","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2237-0902","authenticated-orcid":false,"given":"Gaurav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-4749","authenticated-orcid":false,"given":"Naresh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.diabres.2026.113612_b0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113612_b0010","series-title":"Advanced Concepts in Human Immunology: Prospects for Disease Control","first-page":"161","article-title":"Microbiome and cellular players in type 1 diabetes: from pathogenesis to protection","author":"Badal","year":"2020"},{"issue":"1","key":"10.1016\/j.diabres.2026.113612_b0015","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1038\/s41598-020-65851-y","article-title":"Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes","volume":"10","author":"Badal","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2026.113612_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.756548","article-title":"Partners in crime: beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis","volume":"12","author":"Toren","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2026.113612_b0025","series-title":"IDF Diabetes atlas 11th Edition 2025: Global Prevalence and Projections for 2050","first-page":"7","author":"Duncan","year":"2026"},{"issue":"10","key":"10.1016\/j.diabres.2026.113612_b0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"The Lancet Diab Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0035","doi-asserted-by":"crossref","first-page":"e3207","DOI":"10.1002\/dmrr.3207","article-title":"The remission phase in type 1 diabetes: changing epidemiology, definitions, and emerging immuno\u2010metabolic mechanisms","volume":"36","author":"Zhong","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.diabres.2026.113612_b0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.diabres.2004.10.001","article-title":"Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study","volume":"68","author":"Pozzilli","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.diabres.2026.113612_b0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000479030","article-title":"Remission phase in paediatric type 1 diabetes: new understanding and emerging biomarkers","volume":"88","author":"Fonolleda","year":"2017","journal-title":"Hormone Res Paediat"},{"issue":"8","key":"10.1016\/j.diabres.2026.113612_b0050","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc08-1987","article-title":"New definition for the partial remission period in children and adolescents with type 1 diabetes","volume":"32","author":"Mortensen","year":"2009","journal-title":"Diab Care"},{"issue":"7","key":"10.1016\/j.diabres.2026.113612_b0055","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/pedi.12208","article-title":"Partial remission definition: validation based on the insulin dose\u2010adjusted HbA1c (IDAA1C) in 129 Danish children with new\u2010onset type 1 diabetes","volume":"15","author":"Max Andersen","year":"2014","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2026.113612_b0060","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/pedi.12413","article-title":"Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose\u2010adjusted HbA1c in 3657 children and adolescents from Germany and Austria","volume":"18","author":"Nagl","year":"2017","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0065","doi-asserted-by":"crossref","first-page":"118","DOI":"10.6065\/apem.2040202.101","article-title":"Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission","volume":"26","author":"Wong","year":"2021","journal-title":"Ann Pediat Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113612_b0070","article-title":"The association of autoimmune diseases with type 1 diabetes mellitus in children depends also by the length of partial clinical remission phase (honeymoon)","volume":"2020","author":"Ozen","year":"2020","journal-title":"Int J Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113612_b0075","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nri2192","article-title":"Type 1 diabetes as a relapsing\u2013remitting disease?","volume":"7","author":"Von Herrath","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.diabres.2026.113612_b0080","doi-asserted-by":"crossref","unstructured":"Diabetes* ADAPPCf. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026. Diabetes Care. 2025;49(Supplement_1):S27\u2013S49.","DOI":"10.2337\/dc26-S002"},{"issue":"7","key":"10.1016\/j.diabres.2026.113612_b0085","first-page":"28","article-title":"Effect of linagliptin on incretin-axis and glycaemic variability in T1DM","volume":"66","author":"Mukherjee","year":"2018","journal-title":"J Assoc Physicians India"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-543X.2006.00155.x","article-title":"\u2018The honeymoon phase\u2019in children with type 1 diabetes mellitus: frequency, duration, and influential factors","volume":"7","author":"Abdul-Rasoul","year":"2006","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2026.113612_b0100","doi-asserted-by":"crossref","unstructured":"Palmer J, Fleming G, Greenbaum C, Herold K, Jansa L, Kolb H, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop (vol 53, pg 250, 2004). Diabetes. 2004;53(7):1934\u2013.","DOI":"10.2337\/diabetes.53.1.250"},{"issue":"8","key":"10.1016\/j.diabres.2026.113612_b0105","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/dom.12929","article-title":"Prevalence of elevated liver enzymes in adults with type 1 diabetes: a multicentre analysis of the G erman\/a ustrian DPV database","volume":"19","author":"Stadler","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113612_b0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.diabres.2003.10.017","article-title":"Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus","volume":"64","author":"Takaike","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"10.1016\/j.diabres.2026.113612_b0115","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/dc17-0558","article-title":"Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control","volume":"40","author":"Duca","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0120","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40200-022-01098-w","article-title":"The relationship between GAD65 autoantibody and the risk of T1DM onset","volume":"21","author":"Keshavarzi","year":"2022","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.diabres.2026.113612_b0125","article-title":"Autoantibodies in type 1 diabetes: prevalence and clinical profiles","volume":"17","author":"Hazime","year":"2025","journal-title":"Diab Epidemiol Manag"},{"issue":"6","key":"10.1016\/j.diabres.2026.113612_b0130","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/dc10-2088","article-title":"Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young","volume":"34","author":"Steck","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00125-022-05823-1","article-title":"The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes","volume":"66","author":"Thomas","year":"2023","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2026.113612_b0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/dmrr.1074","article-title":"Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial","volume":"26","author":"Sorkio","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0145","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/dc12-0445","article-title":"Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children","volume":"36","author":"Parkkola","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2026.113612_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5114\/pedm.2021.107165","article-title":"C-peptide and residual \u03b2-cell function in pediatric diabetes - state of the art","volume":"27","author":"Jamio\u0142kowska-Sztabkowska","year":"2021","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"issue":"3","key":"10.1016\/j.diabres.2026.113612_b0155","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"\u03b2-cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2026.113612_b0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4068\/cmj.2017.53.3.216","article-title":"Factors associated with C-peptide levels after diagnosis in children with type 1 diabetes mellitus","volume":"53","author":"Hwang","year":"2017","journal-title":"Chonnam Med J"},{"issue":"8","key":"10.1016\/j.diabres.2026.113612_b0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1515\/jpem-2017-0019","article-title":"Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units\/kg\/day to the gold standard insulin-dose adjusted hemoglobin A1c of \u22649 for the detection of partial clinical remission","volume":"30","author":"Lundberg","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.diabres.2026.113612_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176860","article-title":"A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes","volume":"12","author":"Marino","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2026.113612_b0175","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221145550","article-title":"Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study","volume":"14","author":"Boutsen","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113612_b0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2015.01.005","article-title":"Preproinsulin specific CD8+ T cells in subjects with latent autoimmune diabetes show lower frequency and different pathophysiological characteristics than those with type 1 diabetes","volume":"157","author":"Sachdeva","year":"2015","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113612_b0185","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4103\/ijmr.IJMR_1563_15","article-title":"Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following in vitro stimulation with \u03b2-cell autoantigens","volume":"145","author":"Badal","year":"2017","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.diabres.2026.113612_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115045","article-title":"Preproinsulin-specific regulatory T cell-derived exosomes loaded with immune-checkpoint ligands can suppress autoimmune responses in type 1 diabetes","volume":"161","author":"Basak","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113612_b0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.12998\/wjcc.v12.i1.9","article-title":"Honeymoon phase in type 1 diabetes mellitus: a window of opportunity for diabetes reversal?","volume":"12","author":"Mittal","year":"2024","journal-title":"World J Clin Cases"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:22:23Z","timestamp":1792218143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726005322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"alternative-id":["S0168822726005322"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113612","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and predictors of the honeymoon phase in type 1 diabetes: A longitudinal study from a tertiary care center of north India","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113612"}}